announced on Tuesday. A new transplant method using umbilical cord blood was originally being used to treat the woman’s acute myeloid leukemiabut following the treatment, scientists discovered she had no detectable levels of HIV for 14 months despite discontinuing antiretroviral therapy (ART).
ART involves taking a combination of HIV medicines to manage and treat symptoms, according to the National Institute of Health.
The research was conducted by the International Maternal Pediatric Adolescent AIDS Clinical Trial Network (IMPAACT) P1107 beginning in 2015, according to an NIAID news release announcing the findings.
Researchers observed the outcomes of up to 25 participants living with HIV who underwent a transplant with cord blood stem cells for cancer treatment, hematopoietic disease, or other underlying diseases, the news release continued.